Standard
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial. / Huhn, S; Weinhold, N; Nickel, J; Pritsch, M; Hielscher, T; Hummel, M; Bertsch, U; Huegle-Doerr, B; Vogel, M; Angermund, R; Hänel, M; Salwender, H J; Weisel, K; Dürig, J; Görner, M; Kirchner, H; Peter, N; Graeven, U; Lordick, F; Hoffmann, M; Reimer, P; Blau, I W; Jauch, A; Dembowsky, K; Möhler, T; Wuchter, P; Goldschmidt, H.
In:
BONE MARROW TRANSPL, Vol. 52, No. 8, 08.2017, p. 1194-1198.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
Huhn, S, Weinhold, N, Nickel, J, Pritsch, M, Hielscher, T, Hummel, M, Bertsch, U, Huegle-Doerr, B, Vogel, M, Angermund, R, Hänel, M, Salwender, HJ
, Weisel, K, Dürig, J, Görner, M, Kirchner, H, Peter, N, Graeven, U, Lordick, F, Hoffmann, M, Reimer, P, Blau, IW, Jauch, A, Dembowsky, K, Möhler, T, Wuchter, P & Goldschmidt, H 2017, '
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial',
BONE MARROW TRANSPL, vol. 52, no. 8, pp. 1194-1198.
https://doi.org/10.1038/bmt.2017.91APA
Huhn, S., Weinhold, N., Nickel, J., Pritsch, M., Hielscher, T., Hummel, M., Bertsch, U., Huegle-Doerr, B., Vogel, M., Angermund, R., Hänel, M., Salwender, H. J.
, Weisel, K., Dürig, J., Görner, M., Kirchner, H., Peter, N., Graeven, U., Lordick, F., ... Goldschmidt, H. (2017).
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial.
BONE MARROW TRANSPL,
52(8), 1194-1198.
https://doi.org/10.1038/bmt.2017.91Vancouver
Bibtex
@article{523399f561754e2490d5b050ee76b977,
title = "Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial",
keywords = "Adult, Autografts, Biomarkers, Tumor, Female, Humans, Male, Middle Aged, Multiple Myeloma, Neoplastic Cells, Circulating, Stem Cell Transplantation, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't",
author = "S Huhn and N Weinhold and J Nickel and M Pritsch and T Hielscher and M Hummel and U Bertsch and B Huegle-Doerr and M Vogel and R Angermund and M H{\"a}nel and Salwender, {H J} and K Weisel and J D{\"u}rig and M G{\"o}rner and H Kirchner and N Peter and U Graeven and F Lordick and M Hoffmann and P Reimer and Blau, {I W} and A Jauch and K Dembowsky and T M{\"o}hler and P Wuchter and H Goldschmidt",
year = "2017",
month = aug,
doi = "10.1038/bmt.2017.91",
language = "English",
volume = "52",
pages = "1194--1198",
journal = "BONE MARROW TRANSPL",
issn = "0268-3369",
publisher = "NATURE PUBLISHING GROUP",
number = "8",
}
RIS
TY - JOUR
T1 - Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
AU - Huhn, S
AU - Weinhold, N
AU - Nickel, J
AU - Pritsch, M
AU - Hielscher, T
AU - Hummel, M
AU - Bertsch, U
AU - Huegle-Doerr, B
AU - Vogel, M
AU - Angermund, R
AU - Hänel, M
AU - Salwender, H J
AU - Weisel, K
AU - Dürig, J
AU - Görner, M
AU - Kirchner, H
AU - Peter, N
AU - Graeven, U
AU - Lordick, F
AU - Hoffmann, M
AU - Reimer, P
AU - Blau, I W
AU - Jauch, A
AU - Dembowsky, K
AU - Möhler, T
AU - Wuchter, P
AU - Goldschmidt, H
PY - 2017/8
Y1 - 2017/8
KW - Adult
KW - Autografts
KW - Biomarkers, Tumor
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Multiple Myeloma
KW - Neoplastic Cells, Circulating
KW - Stem Cell Transplantation
KW - Clinical Trial, Phase III
KW - Journal Article
KW - Multicenter Study
KW - Randomized Controlled Trial
KW - Research Support, Non-U.S. Gov't
U2 - 10.1038/bmt.2017.91
DO - 10.1038/bmt.2017.91
M3 - SCORING: Journal article
C2 - 28504661
VL - 52
SP - 1194
EP - 1198
JO - BONE MARROW TRANSPL
JF - BONE MARROW TRANSPL
SN - 0268-3369
IS - 8
ER -
